Advisory Board · Physician-scientist and capital-markets advisor
Fabio A. Jung, MD
MD Anderson on one side. Wharton on the other.
Physician-scientist with an MD Anderson postdoctoral fellowship and a Wharton MBA. Senior Advisor at BCG, with prior managing-director roles at Merrill Lynch, Deutsche Bank, and Bank of America.
Physician-scientist
The Houston column
UFRGS
M.D.
Federal University of Rio Grande do Sul
Porto Alegre
General Surgery residency
Hospital de Clínicas de Porto Alegre
Houston
Postdoctoral fellowship
University of Texas MD Anderson Cancer Center
Capital markets
The Wharton column
Philadelphia
M.B.A.
The Wharton School, University of Pennsylvania
Markets
Managing director / partner-level roles
Merrill Lynch · Deutsche Bank · Bank of America · Investment One Partners
Now
Senior Advisor · Advisory Board
Boston Consulting Group · PHP Biotech
The translation that actually matters
Jung’s value is not that he can “speak both languages.” Plenty of people claim that. It is that he has been in the rooms where an oncology data package is either a scientific object (MD Anderson) or a pricing object (equity research, banking, BCG) — and he knows when a company is performing the wrong play for the room it is in.
Physician-scientist, then markets
Dr. Fabio Jung offers PHP Biotech’s Advisory Board a dual perspective: rigorous medical and oncology-research training combined with more than 20 years of senior investment-banking and strategic-advisory experience.
He completed medical training at the Federal University of Rio Grande do Sul, a postdoctoral fellowship at MD Anderson Cancer Center, and a residency in General Surgery at Hospital de Clínicas de Porto Alegre, then earned an MBA at The Wharton School. He held managing director and partner-level roles at Merrill Lynch, Deutsche Bank, Bank of America, and Investment One Partners, and currently serves as a Senior Advisor at Boston Consulting Group.
Because he can read both a clinical data package and a financial model, Dr. Jung advises on how to frame scientific milestones for investors and evaluate strategic options for PHP53-nb and GEN01-AD.
Curriculum
Education, seats, and expertise
Everything below is meant to be checked. Empty categories are omitted rather than padded.
Education
- M.D., Federal University of Rio Grande do Sul (UFRGS)
- Postdoctoral fellowship, University of Texas MD Anderson Cancer Center
- General Surgery residency, Hospital de Clínicas de Porto Alegre
- M.B.A., The Wharton School of the University of Pennsylvania
Credentials
- MD, Federal University of Rio Grande do Sul (UFRGS)
- Postdoctoral fellowship, MD Anderson Cancer Center
- Residency, General Surgery, Hospital de Clínicas de Porto Alegre
- MBA, The Wharton School, University of Pennsylvania
- Senior Advisor, Boston Consulting Group
Affiliations
- PHP Biotech International Inc. (Advisory Board)
- Boston Consulting Group (Senior Advisor)
- Former postdoctoral fellow, MD Anderson Cancer Center
Expertise
- Oncology development strategy
- Life-science investment banking
- Valuation of platform biotechs
- Partnerships and strategic alternatives
No peer-reviewed papers or patents are listed for Fabio A. Jung, MD. That is intentional. Experience, appointments, and licenses are the E-E-A-T signals on this page — not a fabricated bibliography.